Department of Orthopaedic Surgery, Zhongnan Hospital, Wuhan University, Wuhan, Hubei 430071, China.
Evid Based Complement Alternat Med. 2013;2013:794761. doi: 10.1155/2013/794761. Epub 2013 Jun 4.
This study investigated the effect of Angelica sinensis polysaccharides (APS-3c) on rat osteoarthritis (OA) model in vivo and rat interleukin-1-beta- (IL-1 β -) stimulated chondrocytes in vitro. APS-3c was administrated into rat OA knee joints and had protective effects on rat OA cartilage in vivo. Primary rat articular chondrocytes were cotreated with APS-3c and IL-1 β in vitro. 2~50 μ g/mL APS-3c had no effect on chondrocytes viability, whereas it increased the proteoglycans (PGs) synthesis inhibited by IL-1 β . Microarray analysis showed that the significant changes were concentrated in the genes which were involved in PGs synthesis. RT-PCR confirmed that treatment with APS-3c increased the mRNA expression of aggrecan and glycosyltransferases (GTs) inhibited by IL-1 β but did not affect the mRNA expression of matrix-degrading enzymes. These results indicate that APS-3c can improve PGs synthesis of chondrocytes on rat OA model in vivo and IL-1 β -stimulated chondrocytes in vitro, which is due to the promotion of the expression of aggrecan and GTs involved in PGs synthesis but not the inhibition of the expression of matrix-degrading enzymes. Our findings suggest the clinical relevance of APS-3c in the prospective of future alternative medical treatment for OA.
本研究探讨了当归多糖(APS-3c)对体内大鼠骨关节炎(OA)模型和体外大鼠白细胞介素-1β-(IL-1β)刺激软骨细胞的作用。APS-3c 被给予大鼠 OA 膝关节,并在体内对大鼠 OA 软骨具有保护作用。原代大鼠关节软骨细胞与 APS-3c 和 IL-1β共同孵育。2~50μg/mL 的 APS-3c 对软骨细胞活力没有影响,但增加了 IL-1β抑制的蛋白聚糖(PGs)合成。微阵列分析表明,显著变化集中在参与 PGs 合成的基因上。RT-PCR 证实,APS-3c 处理可增加 IL-1β抑制的聚集蛋白聚糖和糖基转移酶(GTs)的 mRNA 表达,但不影响基质降解酶的 mRNA 表达。这些结果表明,APS-3c 可改善体内大鼠 OA 模型和 IL-1β刺激软骨细胞的 PGs 合成,这是由于促进了参与 PGs 合成的聚集蛋白聚糖和 GTs 的表达,而不是基质降解酶表达的抑制。我们的研究结果表明 APS-3c 在 OA 未来替代医学治疗的前景中具有临床相关性。